Lice Treatment Market by Distribution Channel and Geography - Forecast and Analysis 2022-2026

Published: Mar 2022 Pages: 122 SKU: IRTNTR72486

The lice treatment market share is expected to increase by USD 128.97 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.26%.

This lice treatment market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers lice treatment market segmentation by distribution channel (hospitals and clinics, online, and retail pharmacies) and geography (North America, Europe, Asia, and Rest of World (ROW)). The lice treatment market report also offers information on several market vendors, including Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG among others.

What will the Lice Treatment Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Lice Treatment Market Size for the Forecast Period and Other Important Statistics

 

Lice Treatment Market: Key Drivers, Trends, and Challenges

The increasing prevalence of lice infestation is notably driving the lice treatment market growth, although factors such as high cost of healthcare may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the lice treatment industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Lice Treatment Market Driver

One of the key factors driving growth in the lice treatment market is the increasing prevalence of lice infestation. Infestations by head lice occur widely among children. Most infected individuals do not witness serious symptoms. However, some individuals suffer from severe reactions to louse feeding. Constant itching of the scalp is a common symptom of head lice infestation and can result in the loss of concentration at work or school and sleep. Furthermore, excessive scratching can occasionally pose the risk of lymphadenopathies and secondary skin infections. Hence, such factors will boost the demand for lice treatment solutions during the forecast period.

Key Lice Treatment Market Trend

 

The growing population of children is another factor supporting the lice treatment market share growth. Children are more prone to lice infestation as compared to adults, as they are less protective of their personal space and hygiene. There is a rapid rise in population across the globe; hence, the rising number of children is expected to propel market growth during the forecast period. The rising prevalence of lice infestation is also significantly high in children from nomad tribes, as compared to rural and urban areas due to lack of hygiene and awareness regarding lice infestation. Therefore, the rising number of children across the globe is expected to raise the demand for lice treatment solutions during the forecast period.

This lice treatment market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Key Lice Treatment Market Challenge

The high cost of healthcare will be a major challenge for the lice treatment market during the forecast period. Developed nations such as the US, Canada, and the UK, have high healthcare costs. European countries with the most expensive healthcare systems include Switzerland, Norway, Germany, the Netherlands, Austria, Denmark, Sweden, Ireland, France, Belgium, and Luxembourg. The high cost of healthcare in these developed countries prevents patients from opting for lice treatment options. Additionally, in developing countries such as India, China, Brazil, Argentina, and others, patients are unable to avail of lice treatment due to the lack of resources and low per capita income. The absence of proper healthcare infrastructure and low-amount government aids received in the form of medical expense reimbursement act as a challenge for the patients in these countries. This will negatively affect the growth of the global lice treatment market.

Parent Market Analysis

Technavio categorizes the global lice treatment market as a part of the pharmaceutical market within the overall healthcare industry. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the lice treatment market during the forecast period.

Who are the Major Lice Treatment Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Alliance Pharma Plc
  • American Vanguard Corp.
  • Arbor Pharmaceuticals LLC
  • Elanco Animal Health Inc.
  • Fleming Medical Ltd.
  • Johnson and Johnson Inc.
  • Logic Product Group LLC
  • Marico Ltd.
  • Merck and Co. Inc.
  • Nix Pharma Pvt Ltd.
  • PARAPRO LLC
  • Perrigo Co. Plc
  • Prestige Consumer Healthcare Inc.
  • SHIONOGI Co. Ltd.
  • TecLabs Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Thornton & Ross Ltd.
  • Bayer AG

 

This statistical study of the lice treatment market encompasses successful business strategies deployed by the key vendors. The lice treatment market is fragmented and the vendors are deploying growth strategies such as focusing on offering several products to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The lice treatment market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Lice Treatment Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the lice treatment market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Lice Treatment Market?

For more insights on the market share of various regions Request for a FREE sample now!

32% of the market's growth will originate from North America during the forecast period. The US is the key market for lice treatment in North America. Market growth in this region will be faster than the growth of the market in regions.

The presence of an increasing population of children and a large incidence of lice infestation cases will facilitate the lice treatment market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The governments of countries such as the US, Canada, and Mexico imposed nationwide lockdowns and COVID-related restrictions to curb the spread of the COVID-19 disease. This reduced the number of patients visiting healthcare centers for the treatment of lice infestation, and the regional demand for lice treatment drugs declined. However, in 2021, the number of COVID-19 cases reduced in the region due to the large-scale vaccine administration, which propelled the resumption of elective procedures in hospitals and other healthcare facilities. Thus, the regional demand for lice treatment solutions rebounded.

What are the Revenue-generating Distribution Channel Segments in the Lice Treatment Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The lice treatment market share growth by the hospitals and clinics segment will be significant during the forecast period. The increasing prevalence of head lice among people across the globe is one of the major factors driving the growth of the demand for lice treatment in hospitals and clinics. Factors such as the rising investment for improving the medical formulas for the effective elimination of these parasites are expected to boost market growth during the forecast period. In addition, ease in the availability of lice treatment products in hospitals and clinics will further accelerate market growth. However, patients in underdeveloped and developing countries refrain from consulting a doctor or going to hospitals for lice infestation. This is mainly due to the lower healthcare expenditure and the common perception among people in these regions that lice infestation is not a serious medical concern.

This report provides an accurate prediction of the contribution of all the segments to the growth of the lice treatment market size and actionable market insights on post COVID-19 impact on each segment.

 

Lice Treatment Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 6.26%

Market growth 2022-2026

$ 128.97 million

Market structure

Fragmented

YoY growth (%)

5.7

Regional analysis

APAC

Performing market contribution

North America at 32%

Key consumer countries

US, UK, Germany, China, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Lice Treatment Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive lice treatment market growth during the next five years
  • Precise estimation of the lice treatment market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the lice treatment industry across APAC
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of lice treatment market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Distribution Channel

    • 5.1 Market segments
      • Exhibit 24: Chart on Distribution Channel - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
    • 5.2 Comparison by Distribution Channel
      • Exhibit 26: Chart on Comparison by Distribution Channel
      • Exhibit 27: Data Table on Comparison by Distribution Channel
    • 5.3 Hospitals and clinics - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
    • 5.4 Online - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Online - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Online - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Online - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Online - Year-over-year growth 2021-2026 (%)
    • 5.5 Retail pharmacies - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Retail pharmacies - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Retail pharmacies - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Retail pharmacies - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Retail pharmacies - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by Distribution Channel
      • Exhibit 40: Market opportunity by Distribution Channel ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 UK - Market size and forecast 2021-2026
      • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.9 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.10 Germany - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.11 Japan - Market size and forecast 2021-2026
      • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 82: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 85: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 86: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 87: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 88: Matrix on vendor position and classification
            • 10.3 Alliance Pharma Plc
              • Exhibit 89: Alliance Pharma Plc - Overview
              • Exhibit 90: Alliance Pharma Plc - Business segments
              • Exhibit 91: Alliance Pharma Plc - Key offerings
              • Exhibit 92: Alliance Pharma Plc - Segment focus
            • 10.4 Arbor Pharmaceuticals LLC
              • Exhibit 93: Arbor Pharmaceuticals LLC - Overview
              • Exhibit 94: Arbor Pharmaceuticals LLC - Product / Service
              • Exhibit 95: Arbor Pharmaceuticals LLC - Key offerings
            • 10.5 Bayer AG
              • Exhibit 96: Bayer AG - Overview
              • Exhibit 97: Bayer AG - Business segments
              • Exhibit 98: Bayer AG - Key news
              • Exhibit 99: Bayer AG - Key offerings
              • Exhibit 100: Bayer AG - Segment focus
            • 10.6 Elanco Animal Health Inc.
              • Exhibit 101: Elanco Animal Health Inc. - Overview
              • Exhibit 102: Elanco Animal Health Inc. - Product / Service
              • Exhibit 103: Elanco Animal Health Inc. - Key offerings
            • 10.7 Fleming Medical Ltd.
              • Exhibit 104: Fleming Medical Ltd. - Overview
              • Exhibit 105: Fleming Medical Ltd. - Product / Service
              • Exhibit 106: Fleming Medical Ltd. - Key offerings
            • 10.8 Merck and Co. Inc.
              • Exhibit 107: Merck and Co. Inc. - Overview
              • Exhibit 108: Merck and Co. Inc. - Business segments
              • Exhibit 109: Merck and Co. Inc. - Key news
              • Exhibit 110: Merck and Co. Inc. - Key offerings
              • Exhibit 111: Merck and Co. Inc. - Segment focus
            • 10.9 PARAPRO LLC
              • Exhibit 112: PARAPRO LLC - Overview
              • Exhibit 113: PARAPRO LLC - Product / Service
              • Exhibit 114: PARAPRO LLC - Key offerings
            • 10.10 Prestige Consumer Healthcare Inc.
              • Exhibit 115: Prestige Consumer Healthcare Inc. - Overview
              • Exhibit 116: Prestige Consumer Healthcare Inc. - Business segments
              • Exhibit 117: Prestige Consumer Healthcare Inc. - Key offerings
              • Exhibit 118: Prestige Consumer Healthcare Inc. - Segment focus
            • 10.11 Teva Pharmaceutical Industries Ltd.
              • Exhibit 119: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 120: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 121: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 122: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 123: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 10.12 Thornton Ross Ltd.
              • Exhibit 124: Thornton Ross Ltd. - Overview
              • Exhibit 125: Thornton Ross Ltd. - Product / Service
              • Exhibit 126: Thornton Ross Ltd. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 127: Inclusions checklist
                • Exhibit 128: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 129: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 130: Research methodology
                • Exhibit 131: Validation techniques employed for market sizing
                • Exhibit 132: Information sources
              • 11.5 List of abbreviations
                • Exhibit 133: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              lice treatment market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis